Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655337
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-21
Brief Title:
Efficiency of the medidux Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit AAU
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficiency of the medidux Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit AAU a Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EffiDux
Brief Summary:
The goal of this clinical trial is to evaluate whether the use of the medidux smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units AAU with non-urgent health complaints This trial includes adult patients age 18 in Emergency Severity Index ESI triage system groups 4 standard or 5 non-urgent presenting with primary symptoms such as cough back pain or abdominal discomfort
The main question it aims to answer is
Can the medidux app reduce the incidence of AAU readmissions emergency hospitalizations or consultations with other medical providers within 7 days after initial admission
Researchers will compare participants using the medidux app intervention arm with those receiving standard care control arm to observe potential differences in the rates of readmissions emergency hospitalizations and medical consultations
Participants will
use the medidux app to monitor their symptoms and vital parameters for 7 days after discharge intervention arm
receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions both arms
The main question it aims to answer is
Can the medidux app reduce the incidence of AAU readmissions emergency hospitalizations or consultations with other medical providers within 7 days after initial admission
Researchers will compare participants using the medidux app intervention arm with those receiving standard care control arm to observe potential differences in the rates of readmissions emergency hospitalizations and medical consultations
Participants will
use the medidux app to monitor their symptoms and vital parameters for 7 days after discharge intervention arm
receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions both arms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None